AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Market Cap $14.95M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Last update - 16.00pm 31/07/2026 (20 minute delay)
?
| Day | ||||||||
|---|---|---|---|---|---|---|---|---|
| Open | 3.8¢ | Day High | 3.8¢ | Day Low | 3.8¢ | |||
| Daily Volume | 289622 | |||||||
| Bids | Sellers | |||||
|---|---|---|---|---|---|---|
| Number | Price | Volume | Number | Price | Volume | |
| 0 | 3.8¢ | 65810 | 0 | 4.0¢ | 31260 | |
Directors & Senior Management
| Mr. Geoffrey Joseph Sam | Independent Non-Executive Director |
| Dr. Jane Ryan | Independent Non-Executive Director |
| Mr. Jim Sosic | Chief Operating Officer |
| Mr. Malika Perera | Head of Finance |
| Mr. Mark Andrew Licciardo | Company Secretary |
| Mr. Mark Anthony Simari | Independent Non-Executive Chairman |
| Mr. Michael B. Thompson | Director of Commercial & Business Development |
| Ms. Paula Coutts | Director of People & Safety |
| Mr. Robert Caunce | Director of Quality |
Data source: ADVFN
